Dimethylglycine
metaboliteDysregulated one-carbon metabolism and methylation homeostasis associates with myocardial-infarction and heart-failure risk.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencehigh
RationaleOne-carbon metabolism; betaine metabolite; incident CVD and MI risk via systemic metabolic axis.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(3)
- Large-Scale Metabolomics and the Incidence of Cardiovascular Disease.Journal of the American Heart Association · 2023 · PMID 36645074 · doi
- Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris.Arteriosclerosis, thrombosis, and vascular biology · 2013 · PMID 23723367 · doi
- Betaine and secondary events in an acute coronary syndrome cohort.PloS one · 2012 · PMID 22649561 · doi